IMCIVREE (setmelanotide)

IMCIVREE is indicated for the chronic weight management in those with Bardet-Biedl syndrome (BBS), pro-opiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency obesity in adult and pediatric patients 6 years of age and older.

www.imcivree.com